SCC- Principles
Drugs for TB treatment can be given daily or intermittently Intermittent regimens are either bi- weekly or thrice weekly regimens Therapy is supervised or unsupervised Course divided into two phases: initial / intensive phase & continuation / maintenance phase Priority is given to sputum positive cases
Intermittent Chemotherapy
weekly.
Rationale: Organism multiplication time is 18 hrs Lag period exhibited by Mycobacterium 24 hours maintenance of MIC not necessary. Achievement of serum peak levels of all drugs simultaneously is essential.
Type of cases
New case: Patient who has not received ATT or has received treatment for < one month Relapse: Patient declared cured but reports back & sputum is positive for AFB Treatment after default: Patient who receives ATT for a month or more but stops taking drugs for two months or more consecutively
Type of cases
Failure
case: Patient who is smear positive after 5 months or more after starting treatment OR patient initially smear negative but becomes smear positive during treatment Chronic case: Patient who remains smear positive after completing a retreatment regimen
Dormant bacilli
Rifampicin:
Meditarraneae
Bactericidal & inhibits DNA dependent RNA polymerase Active against persisters Absorbed better on an empty stomach Side affects- Anorexia, nausea, vomiting, abdominal pain, diarrhoea, immune mediated flu like syndrome, thrombocytopenia & ARF Increase dosage requirements of corticosteroids, OCP, oral anti coagulants, phenytoin, digitalis, cyclosporine's
Ethembutol: Bacteriostatic
Inhibits RNA arabinogalactan synthesis Side effect is retro bulbar neuritis Contra indicated in children
Pyrazinamide :
Synthetic
pyrazine analogue of nicotinamide Bactericidal in acidic PH Acts by inhibiting nicotinic acid metabolism Adverse effect: Hepatotoxicity, arthralgia, hyperurecemia
INH Rifampicin
PZA
5 10
25
10 10
35 15 30
15 10
50 15 45
Streptomyc 15 in Ethambutol 15
TB treatment regimens
TB TB patients category Initial phase Continuation phase
2EHRZ or 2E3H3R3Z3 4HR or 4H3R3
New
sputum positive
failures
Sputum
by WHO as essential strategy in TB control Enforced due to rising incidence of HIV and MDR-TB
4.
5.
Political commitment Passive case finding by sputum smear examination Continuous & uninterrupted supply of anti TB treatment System to report & monitor the outcome of treatment Compliance achieved by monitoring drug intake by health workers, community volunteers, family members or after hospitalization
Diagnosis of Pulmonary TB
Cough 3 weeks If 1 positive, X-ray and evaluation
AFB X 3
If negative: Broad-spectrum antibiotic 10-14 days If symptoms persist, X-ray If consistent with TB
Anti-TB Treatment
Corticosteroids in TB
In drug hypersensitive reactions In some cases of TB meningitis TB pericarditis Hypoadrenalism TB laryngitis Renal TB Massive Lymph node enlargement with pressure effects Some cases of TB pleural effusion